title: Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics.
abstract: Lactobacillus sp. FTDC 2113, L. acidophilus FTDC 8033, L. acidophilus ATCC 4356, L. casei ATCC 393, Bifidobacterium FTDC 8943 and B. longum FTDC 8643 were incorporated into soymilk supplemented with fructooligosaccharides (FOS), inulin, mannitol, maltodextrin and pectin. The objective of the present study was to evaluate the effects of prebiotics on the bioactivity of probiotic-fermented soymilk. Proteolytic activity was increased in the presence of FOS, while the supplementation of inulin and pectin increased the angiotensin I-converting enzyme inhibitory activity accompanied by lower IC(50) values. The beta-glucosidase activity was also enhanced in the presence of pectin. This led to higher bioconversion of glucosides to aglycones by probiotics, especially genistin and malonyl genistin to genistein. Results from this study indicated that the supplementation of prebiotics enhanced the in-vitro antihypertensive effect and production of bioactive aglycones in probiotic-fermented soymilk. Therefore, this soymilk could potentially be used as a dietary therapy to reduce the risks of hypertension and hormone-dependent diseases such as breast cancer, prostate cancer and osteoporosis.
authors.affiliation: School of Industrial Technology, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia.
authors.forename: Siok-Koon
authors.initials: SK
authors.lastname: Yeo
authors.forename: Min-Tze
authors.initials: MT
authors.lastname: Liong
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000378:metabolism / Q000494:pharmacology*; D001644:Bifidobacterium; D001711:Biotransformation; D019587:Dietary Supplements; D005285:Fermentation; D005527:Food, Fortified; D019833:Genistein / Q000378:metabolism / Q000494:pharmacology; D005960:Glucosides / Q000378:metabolism; D006868:Hydrolysis; D020128:Inhibitory Concentration 50; D007529:Isoflavones / Q000378:metabolism / Q000494:pharmacology*; D007777:Lactobacillaceae; D009844:Oligosaccharides; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*; D056692:Prebiotics; D019936:Probiotics; D041942:Soy Milk; D030262:Soybean Proteins / Q000378:metabolism; D013025:Glycine max; D001617:beta-Glucosidase / Q000378:metabolism
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D005960:Glucosides; D007529:Isoflavones; D009844:Oligosaccharides; D010455:Peptides; D056692:Prebiotics; D030262:Soybean Proteins; C040641:genistin; D019833:Genistein; D001617:beta-Glucosidase